Center Partnerships Diabetes Research Centers now highlights DRC Partner Institutions. Center partnerships are listed with location details and links to the partnership website. An overview of the partner institution and its research centers, institutions, and programs can also be viewed.

DIABETES RESEARCH CENTERS

Jonathan S Bogan Jonathan S Bogan Yale University Yale University
Dr. Bogan’s research seeks to understand how glucose uptake is regulated in fat and muscle cells. In these cell types, insulin causes glucose transporters to move from internal membranes to the cell surface. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Roland W Stein Roland W Stein PhD Vanderbilt University Vanderbilt University
Until recently, little detailed information was known about the factors controlling pancreas development and islet beta cell function. However, our understanding has increased greatly with the identification and molecular characterization of the islet-enriched MafA, MafB, and PDX-1 transcription factors. The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
Gerald I Shulman Gerald I Shulman MD PhD Yale University Yale University
Dr. Shulman is the George R. Cowgill Professor of Medicine, Cellular & Molecular Physiology and Physiological Chemistry at Yale University, where he serves as Co-Director of the Yale Diabetes Research Center and Director of the Yale Mouse Metabolic Phenotyping Center. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Mitchell A Lazar MD PhD University of Pennsylvania University of Pennsylvania
The Lazar laboratory is studying the transcriptional regulation of metabolism. We are particularly focused on the role played by nuclear receptors. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Andrea L Cherrington Andrea L Cherrington MD MPH University of Alabama at Birmingham University of Alabama at Birmingham
Dr. Cherrington is committed to efforts that bridge the gap between the health care system and underserved communities. Her research focuses on developing, implementing and evaluating community-based interventions to improve the outcomes of disadvantaged populations at high risk for developing chronic disease- specifically diabetes. The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Fumihiko Urano Fumihiko Urano MD PhD Washington University in St Louis Washington University in St Louis
Dr. Urano’s current main focus is to find a cure for juvenile diabetes and genetic forms of diabetes including Type 1 diabetes and Wolfram syndrome using stem cell-based therapeutics and gene-based diagnostics. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Ji Lei MD MBA Boston Area Boston Area
Dr. Ji Lei is the director of the special service GMP facility for human islet/cell isolation and transplantation at Massachusetts General Hospital. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
David Maahs MD PhD Stanford University Stanford University
Dr. Maahs is Professor of Pediatrics and Division Chief of Pediatric Endocrinology at Stanford University and the Lucile Packard Children’s Hospital. His research focuses on improving care and preventing complications in people with type 1 diabetes (T1D). The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Holden T Maecker PhD Stanford University Stanford University
Dr. Maecker’s research has illuminated T cell response signatures and their association with protection from chronic pathogens and cancer. His lab has published a number of important papers on this topic, both alone and in collaboration with other groups. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Karin Bornfeldt Karin Bornfeldt PhD University of Washington University of Washington
The Bornfeldt laboratory is dedicated to understanding the cellular and molecular mechanisms of diabetes-accelerated cardiovascular disease, so that these complications can be effectively treated or prevented. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Christin Carter-Su Christin Carter-Su PhD University of Michigan University of Michigan
A major and longstanding interest of our laboratory is the delineation of the cellular and molecular mechanisms by which growth hormone (GH) regulates body growth and metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
David A Antonetti PhD University of Michigan University of Michigan
Investigations into the formation and loss of the blood-brain and blood-retinal barrier in normal vascular biology, diabetes, cancer and stroke. Our long-term goal is to contribute to the development of novel treatments to prevent or reverse the debilitating loss of vision from diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Mark O Goodarzi MD PhD UCSD-UCLA UCSD-UCLA

The laboratory of Mark O. Goodarzi, MD, PhD, seeks to identify genetic factors underlying conditions related to insulin resistance and the metabolic syndrome, using a population genetic approach.

The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Steven E Kahn MB ChB University of Washington University of Washington
Dr. Kahn received his medical degree from the University of Cape Town, South Africa. He is an endocrinologist whose research focuses on the mechanisms responsible for the critical impairments in insulin secretion that result in the development of diabetes. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Irfan Lodhi PhD Irfan Lodhi PhD Washington University in St Louis Washington University in St Louis

Irfan Lodhi received his PhD in Cellular and Molecular Biology from the University of Michigan Medical School, where he studied signaling pathways involved in insulin-stimulated glucose transport in adipocytes under the mentorship of Dr. Alan Saltiel. In 2007, he joined Dr.

TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Jose C Florez MD PhD Jose C Florez MD PhD Boston Area Boston Area
Dr. Florez’s research interests lie on the genetic determinants of type 2 diabetes and related metabolic traits, and how these variants may impact disease prediction and therapeutic choices. Thus his laboratory leads two parallel efforts in gene discovery and pharmacogenetics. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
UCSD-UCLA UCSD-UCLA Albert Einstein College of Medicine Einstein University of Michigan Michigan 
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis., Wheeler, Eleanor, Leong Aaron, Liu Ching-Ti, Hivert Marie-France, Strawbridge Rona J., Podmore Clara, Li Man, Yao Jie, Sim Xueling, Hong Jaeyoung, et al. , PLoS Med, 2017 Sep, Volume 14, Issue 9, p.e1002383, (2017)
NIDDK Center
The Cystic Fibrosis Research and Translation Centers are part of an integrated program of research support designed to enhance multidisciplinary research in pathogenesis and treatment of cystic fibrosis.
Diabetes Resource
Look AHEAD (Action For Health in Diabetes) is a multi-center randomized clinical trial to examine the effects of a lifestyle intervention designed to achieve and maintain weight loss over the long term through decreased caloric intake and exercise.